Key issues reflected to revised bill of pharmaceutical affairs law.

Published: 2000-12-11 15:58:00

Updated: 2000-12-11 15:58:00

The key issues earlier agreed in the 3 way talks among the government, the medical and the pharmacy representative groups will be reflected to the revised bill of the pharmaceutical affairs law. The revised bill contains a prohibition clause on the business collusion between medical institutes an...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK